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Correlation of distribution of sulphonated aluminium phthalocyanines
with their photodynamic effect in tumour and skin of mice bearing CaD2
mammary carcinoma
Q Peng' and J Moan:
Departments of- Pathology and Biophvsics. Institute for Cancer Research, The Norwiegian Radium Hospital, Montebello. 0310
Oslo, NorwaY.
Summan- A chemical extraction assax- and fluorescence microscopi incorporating a light-sensitive ther-
moelectnically cooled charge-coupled device (CCD) camera was used to study the kinetics of uptake. retention
and localisation of disulphonated aluminium phthalocyanine (AIPcS-) and tetrasulphonated aluminium
phthalocvanine (AlPcS4) at different time inten-als after an i.p. injection at a dose of 10 mg kg` body w-eight
(b.Ax in tumour and surrounding normal skin and muscle of female C-D F, mice bearing CaD2 mammary
carcinoma. Moreover. the photodymamic effect on the tumour and normal skin using sulphonated aluminium
phthalocvanines (AIPcS,. AIPcS:. AlPcS4) and Photofrin was compared w-ith respect to dye, dve dose and time
interval betu-een dve administration and light exposure. The maximal concentrations of AlPcS in the tumour
tissue w-ere reached 2-24 h after injection of the dve. while the amounts of AIPcS4 peaked 1-2 h after the dve
administration. AlPcS, was simultaneouslv localised in the interstitium and in the neoplastic cells of the
tumour. uhereas AlPcS4 appeared to localise only in the stroma of the tumour. The photodynamic efficiency
(light A-as applied 24 h after dye injection at a dose of 10mg kg-' b.wu. of the tumours u-as found to decrease
in the folloWing order: AlPcS >AIPcS4>Photofrin >AlPcSl. Furthermore. photodynamic efficacyv was
strongly dependent upon dye doses and time intervals betw-een dye administration and light exposure: the
higher the dose. the higher the photodynamic efficiency. The most efficient photodynamic therapy (PDT) of
the tumour u-as reached (day 20 tumour-free) when light exposure took place 2 h after injection of AlPcS,
(10 mg k-.) A dual intratumoral localisation pattern of the dye. as found for AlPcS:. seems desirable to
obtain a high photodynamic efficiency. The kinetic patterns of uptake. retention and localisation of AlPcS,
and AIPcS4 are roughly correlated w-ith their photodynamic effect on the tumour and normal skin.
Keywords: photodynamic therapy: sulphonated aluminium phthalocyanines: Photofrin: mouse CaD2 mam-
marv carcinoma: fluorescence microscopy
Although observations that phthalocyamines had affinity for
tumour tissues were documented more than 30 years ago (see
references in Rosenthal. 1991). interest in phthalocvanines as
second-generation photosensitisers for photodynamic therapy
(PDT) of cancer arose in 1985 w-hen Ben-Hur and Rosenthal
(1985) reported that some phthalocyanines were efficient
photosensitisers in mammalian cells. Phthalocyanines (Pcs)
can be regarded as azaporphynins containing a nng system
made up of four isoindoles linked by nitrogen atoms. Several
diamagnetic metal ions can be inserted into the central ring
of the Pc macrocvcle. such as aluminium. gallium, tin and
zinc. leading to high triplet yields as well as long triplet
lifetimes of some of the metallo-Pcs (M-Pcs). M-Pcs are
insoluble in water. but water-soluble M-Pcs can be obtained
by sulphonation procedures. At present. most studies on Pcs
related to PDT have been conducted with water-soluble sul-
phonated M-Pcs. in particular sulphonated aluminium
phthalocvanines (AlPcS,s). M-Pcs have several advantages
over haematoporphyrin derivative (HpD) and Photofrin. the
dyes currently most used in clinical trials, such as high
chemical stability and a well-defined chemical structure
(Spikes. 1986: Rosenthal. 1991). Moreover. M-Pcs have an
absorption peak around 650-700 nm (Q-band) besides an
ultraviolet peak (350 nm). The extinction coefficient of the
Q-band used for PDT is about 50 times higher than that of
HpD Photofrin. thus probably allowing a more efficient
utilisation of photons. Furthermore, the absorption peak of
M-Pcs in the Q-band is red-shifted by about 50 nm compared
with those of HpD Photofrin. This results in approximately
50% deeper tissue penetration of the activating light (Ben-
Hur and Rosenthal. 1986).
Initially, the majority of these studies employed AIPcS in
the form of a mixture containing monosulphonated. disul-
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phonated. trisulphonated and tetrasulphonated components
(van Lier and Spikes. 1989: van Lier. 1990). Recently, more
detailed studies using AlPcS,s with different degrees of sul-
phonation have been carried out. It has been shown that the
degree of sulphonation of AlPcS,s could significantly affect
the distnrbution and the PDT effect of the dyes in some
tumour and normal tissues of mice (Chan et al.. 1990. 1991:
Peng et al.. 1991a. 1993: Boyle et al.. 1992; van Leengoed et
al.. 1993a).
The phenomenon of preferential distribution (uptake and
localisation) of a sensitiser in tumours is a basis for selective
eradication of neoplasia by PDT. The concentration of a dye
within a tumour varies with time after administration. Also.
the intratumoral localisation pattern of the dye in the tumour
depends upon time course (Peng et al.. 1990a; 1991b). which
may affect PDT efficacy. Thus. the optimal time interval
between sensitiser application and its subsequent activation
by light is a crucial factor for success of PDT. However, few
data exist as to correlation of uptake and localisation of
M-Pcs in tumours with their photodynamic effect. although a
large number of reports indicate the potential utility of M-
Pcs as sensitisers for PDT of tumours (Spikes. 1986: van
Lier. 1990: Rosenthal. 1991). In the present work, we have
studied uptake. elimination. localisation and photodynamic
efficacy of AlPcS, and AlPcS, in tumours and normal skin of
mice bearing CaD2 mammarv carcinoma.
Materials and methods
Chemicals
Derivatives of aluminium phthalocyanines with mono-. di-
and tetrasulphonate groups (AlPcSj. AlPcS, and AlPcS,)
were obtained from Porphyrin Products (Logan. UT. USA).
These derivatives were assessed by high-performance liquid
chromatography (HPLC) to be >90% pure (Berg et al..Dish&--n aiodPDT dhcs d pmh"aes
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1989). The dye called AlPcS, in the present study probably
contains two sulphonate groups on adjacent phenyl rings
(AlPcS2,). Stock solutions of AlPcS2 and AIPcS4 were
prepared in Dulbecco's phosphate-buffered saline (PBS)
(Gibco), while AlPcS, was dissolved initially in a small
amount of 40% ethanol in PBS followed by dilution in PBS.
All solutions of AlPcS,s were sonicated for 5 min (Elma
Transsonic, type T400, Germany) before use in order to
reduce the degree of aggregation. All chemicals used were of
the highest purity commercially available.
Animals and twnour line
Female C3D2 Fl mice were obtained from Bomholtgaard, Ry,
Denmark, housed eight per cage and kept under specific
pathogen-free conditions. The mice were 6 weeks old and
weighed 20-22 g when the experiments started. The CaD2
mouse mammary carcinoma (German Cancer Center,
Heidelberg, Germany) was propagated by serial transplanta-
tion into the C3D2JF, mice. Non-necrotic tumour material for
inoculation was obtained by sterile dissection of large flank
tumours from syngeneic mice. Macroscopically viable tumour
tissue was gently minced with a pair of scissors and forced
repeatedly through sterile needles of diminishing sizes from
19 gauge to 25 gauge to make a tumour tissue suspension,
0.02 ml of which was then injected into the dorsal side of the
right hind foot of each mouse. The rate of successful trans-
plantations was nearly 100% in the present experiments. No
spontaneous necrosis was observed in the tumours which
grew to reach 5-7 mm transverse diameter on the day of
treatment, as measured with a caliper. The tumour volume
was calculated using the following formula:
V = x 6(D, x D, x D3)
where DI, D, and D3 are three orthogonal diameters of the
tumours which were measured daily by the caliper (Evensen
and Moan, 1987).
Uptake and elimination ofAlPcS, andAlPcS, in tumour and
surrounding normal tissues
When the tumours had reached the appropriate size (as
indicated above), the mice were given an i.p. injection of
10 mg kg-' b.w. of either AlPcS2 or AlPcS4. At 0.5, 1, 2, 4,
24, 48, 72, 96 and 120 h (five mice for each time point) after
the injection the mice were killed by cervical dislocation. The
tumour, normal skin overlying the tumour and adjacent nor-
mal thigh muscle were removed for determination of AlPcS2
and AlPcS4. The same tissue samples were also taken from
control mice receiving no dye. Extraction of AlPcSJ/AlPcS4
from various tissue samples was carried out according to
Chan et al. (1988) with slight modification. Briefly, the tissue
samples were digested with 0.1 M sodium hydroxide (0.1 g of
wet tissue in 5 ml of 0.1 M sodium hydroxide) for 4h in a
50°C water bath with constant shaking. It was found that
such a treatment (i.e. 50°C for 4 h in 0.1 M sodium hydroxide
solution) did not alter the fluorescence spectra or the
fluorescence intensity of test samples containing AlPcS2 or
AlPcS4. The resulting solutions were centrifuged at
3000 r.p.m. (1600 g) for 10 min, after which the drug levels in
the supernatant were determined by recording fluorescence
emission spectra using a Perkin-Elmer LS-5 luminescence
spectrofluorimeter. The excitation wavelength was set at
350 nm for both of the drugs, the emission slit width was
5.0 nm and the emission wavelength was scanned from 550 to
750 nm. A cut-off filter was used to remove scattered light of
wavelength shorter than 545 nm from the light reaching the
detection system of the spectrometer. The absolute amounts
of the dyes in tissues were calculated from standard curves
made by addition of known amounts of the dye to corres-
ponding tissue extracts from control mice receiving no injec-
tion of the dye, and expressed as ILg of AlPcS2 or AIPcS4g-'
wet tissue.
Localisation ofAlPcS2 and AlPcS4 in the tumour and
surrounding normal tissues
In the uptake study the tumour and surrounding normal skin
and muscle tissues at 2, 24, 48, 72 and 120 h after injection of
either AlPcS2 or AlPcS4 were excised and immediately
bisected. One half of each tissue sample was used for the
extraction assay and the other half was prepared for the
localisation study. The samples were immediately immersed
in liquid nitrogen, then mounted in medium (Tissue Tek II
embedding compound; BDH, Poole, UK). Sections were cut
with a cryostat to a thickness of 8 gm and mounted on clean
glass slides. A series of sections were cut from each tissue
block. The fluorescence localisation pattern of AlPcS2 or
AlPcS4 in each section was directly observed by fluorescence
microscopy. The same frozen sections were subsequently
stained with haematoxylin and eosin (H&E).
Comparisons were made between the fluorescence images and
ordinary micrographs of H&E-stained specimens in order to
determine the exact histological localisation of AIPcS2 and
AlPcS4 in the tissues. The fluorescence microscopy was car-
ried out using an Axioplan microscope (Zeiss, Germany)
with a 100 W mercury lamp. The fluorescence images were
recorded by a highly light-sensitive thermoelectrically cooled
charge-coupled device (CCD) camera (resolution 385 x 578)
(Astromed CCD 3200, Cambridge, UK) and hardcopied on a
video printer (Sony multiscan video printer UP-930). The
filter combination used for detection of AlPcS,/AlPcS4
fluorescence consisted of a 365 nm excitation filter, a 395 nm
beam splitter and a >600 nm emission filter.
PDTefficiency ofthe tumour with AlPcS1, AlPcS2, AlPcS4 or
Photofrin
Mice with tumours of the appropriate size were divided into
four groups for each drug: group 1, neither a dye nor light,
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Ftgwe 1 The quantities of (a) A1PcS2 and (b) AIPcS4 extracted
from CaD2 tumours (0), skin (M) and muscle (A) as a function
of time after an i.p. injection at a dose of 10 mgkg-'. Bars (s.d.)
are based on five individual animals.
Lonly i.p. administration of 0.1 ml of PBS; group 2, light only
on the tumour, group 3, mice given an i.p. I0 mgkg-'
inJection of AlPcS,, AIPcS2 or AIPcS6 without light exposure;
group 4, mice given an i.p. injection of one of the AIPcS.
derivatives at different doses (1, 5 and 1Omg kg-'). At 2, 24
and 72 h after injection, the tumours were irradiated (various
numbers of mice per drug and time point as indicated in the
figures). In a separate group mice (ten mice) bearing the same
tumour model were given an i.p. injection of 10 mg kg-' b.w.
Photofrin. After 24 h (a standard time for animal and clnical
studies with the dye) the tumours were exposed to light.
Responses of the treated tumours were evaluated as tumour
regression/regrowth time. The size of the tumours was
measured every day, and when the treated tumours reached a
volume five times that of the volume on the day just before
light irradiation the mice were sacrificed. The data based on
the measurements of tumour volumes from each group were
pooled to represent mean tumour growth curves.
Tlhe laser light irTadiation of the tumours was performed
as previously described (Evensen and Moan, 1987). Unanaes-
thetised mice were fixed in Lucite Jigs secially designed for
irradiation. The tumour area was exposed to red light from a
dicyanomethylane-2-methy- mylaminoyryl)-4H-
pyran (DCM) dye laser pumped by a 5 W argon ion laser
(Spectra Physics, 164). The tuning range was 610-690 nm.
The dye Lasr was tuned at 675 nm for all derivatives of
AlPcS. and at 632 nm for Photofrin, the tuning being cont-
rolled by means of a monochromator. The laser beam was
defocused by means of a microscopic ocular. The light was
delivered at a fluence rate of 150mW cm-2 for 15 min
exposures in all cases. The fluence rate of the light on the
tumour area was regularly controlled by a calibrated integ-
rating sphere with a photodiode coupled to a digital mul-
timeter (Keithley Instruments, Germany) before and
immedi;ately after light illumination.
PDTeffect on normal skin ofmice with AlPcS,, AlPcS2,
AlPcS4 or Photofrin
The normal foot response of C3D,/Fl mie bearing no
tumour (3-5 mice per group) to PDT was evaluated. These
normal mice were treated with PDT using the derivatives of
AlPcS. or Photofnn in the exactly same manner as those
bearing tumours. Different doses of the drugs (1, 5 and
l0mgkg-1 for derivatives of AlPcS. and l0mgkg-' for
Photofrin) and time intervals between drug administration
and light exposure (2, 24, 48 and 72 h for AlPcSs and 24h
for Photofrin) were employed. The light was used at the same
doses as those for PDT of tumours. The PDT-induced res-
ponse of right hind feet of mice was compared with that of
the unexposed left hind feet of the same mice as follows:
1. The average thickness (PDT-induced oedema) of the
treated foot (T,) and of the untreated foot (T.) (Evensen
and Moan, 1987) was measured every second day for 24
days; the response was calculated as (T,/T.) -1.
2. The foot response was graded every second day accord-
ing to the following arbitrary score, in which each score
was also divided into five subscores (0.2 for each) based
on the reaction degree: 0, no difference from normal;
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0.2-1, slight swelling and mild erythema; 1.2-2, severe
swelling (or with exudation), erythema or slight necrosis;
2.2-3, necrosis and crust.
3. Histopathological observation 1, 5, 10 and 20 days after
treatment.
Res
Uptake and retention ofAlPcS2 andAlPcS4 in tumour and
normal tissues
The kinetics of uptake and retention of AlPcS2 and A1PcS4
by the CaD2 tumours and surrounding normal skin and
muscle tissues is shown in Figure 1. The maximal concentra-
tions of AIPcS2 in the tumours were reached 2-24 h after
injection of the dye. After that, the concentrations gradually
decreased with time. The amounts of AIPcS4 in the tumours
peaked at 1-2 h after the dye administration, after which the
concentrations declined at a faster rate than that of AIPcS2.
Both of the dyes had a similar kinetic pattern of uptake and
elimination in the surrounding normal skin and muscle
(Figure 1). The absolute levels of AIPcS2 and AIPcS4 were
much lower in the muscle than in the tumour and skin
(Figure 1). The concentration ratios of tumour-skin and
tumour-muscle at different time intervals after injection of
AIPcS2 or AIPcS4 are presented in Table I. The concentra-
tions of AIPcS2 in the tumour were 0.7-2.2 times as high as
those in the skin and 2.5-13 times as high as those in the
muscle during the period studied. In the case of AIPcS4, the
dye was taken up 0.9-1.7 times more in the tumour than in
the skin and 2-12 times more in the tumour than in the
muscle.
Localisation ofAlPcS2 andAlPcS4 in the tu,nour and
sUrrouni normal ties
Strong fluorescence of AlPcS2 was seen in the connective
tissue and vascular srctue ofdermis surrounding the CaD2
tumour and also, to some extent, in the neoplastic cells ofthe
tumour tissue as early as 2 h after injection of the dye
(Figure 2a). The fluorescence of the intacellularly lcalised
dye in the tumour tissue was strong 24-72 h after the injc-
tion (Figure 2b), while almost no fluorescence could be
detected 120h after the injection. Fluorescence of the dye
was hardly seen in the epidermis and muscle in the time
invervals studied. In the case of AIPcS4, there was a strong
fluorescence of the dye in the connective tissue and vessels of
the dermis around the tumour 2 h post injection (Figure 2c).
At 24-72 h after injection much less flowscence of the dye
was found in the dermis surrounding the tumour. Some
fluorescence appeared to localise mainly in the stromal com-
ponents of the tumours (Figure 2d). No fluorescence of the
dye was found in the epidermis and muscle.
PDTefficiency oftumours with AlPcS,, AlPcS2, AlPcS4 or
Photofrin
The growth of the tumours exposed to light 24 h after an i.p.
administration of AIPcSI, AlPcS2, AlPcS4 or Photofrin at a
Table I The concentration ratios of tumour-skin and tumour-muscle in mice bearing CaD2 mammary carinoma at different times after an
i.p. injecton of 10mg kg-' A1PcS2 or AlPcS4
AJPcS2 AIPcS4 Time (h) Tumour-skin Twnour-muscle Tumour-skin Tuwur-muscle
0.5 1.7 4.8 0.9 2.2
1 1.4 4.2 1 2
2 1.2 2.5 1.1 2.5
4 1.2 3.4 1.2 2.9
24 1.5 9.2 1.7 10
48 2.2 13 1.3 12
72 1.9 12 1.4 12
96 1.4 10 1.3 10
120 0.7 8 1.2 12Disib-on and PDT decso d phocy e
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dose of 10 mg kg-' is shown in Figure 3. The control
tumours (neither dye nor light) grew exponentially with a
doubling time of about 1.6 days. Laser light given to
tumours of mice receiving no injection of the dye had a slight
but insignificant effect on the tumour growth. Tumours of
mice treated with AlPcS,-PDT grew a little more slowly
than did the control tumours. However. tumours of mice
given AlPcS2 or AIPcS4 followed by light exposure showed a
significant growth delay. Among the dyes studied, AlPcS,
was the most efficient photosensitiser, being significantly
more efficient than AlPcS4 and Photofrin. The PDT
efficiencies in the tumour model were found to decrease in
the following order: AlPcS2>AlPcS4> Photofrin> AlPcS1
(Figure 3). It should be noted that tumours treated with
Photofrin-PDT approached the same growth rate as that of
control tumours (6-10 days after PDT), in agreement with
our earlier work (Evensen and Moan, 1987), while the
tumours treated with AIPcS,- or AlPcS4-mediated PDT had a
reduced growth rate during the whole period of observation.
PDT was more efficient when light irradiation was applied at
2 h than at 24 or 72 h post dye injection in both cases of
AlPcS2 and AlPcS4 (Figure 4). The tumours treated with
AlPcS2 followed, 2 h later, by light exposure did not resume
growth during the 20 days examined. Moreover, as can be
a
c d
Fire 2 Fluorescence photomicrographs of CaD2 tumours sampled 2 h (a and c) and 24 h (b and d) after an i.p. injection of
AlPcS, (a and b) or A1PcS4 (c and d) at a dose of 1Omg kg-'. (a) Strong fluorescence of the dye mainly in the stroma of the
tumour. (b) Fluorescence in the neoplastic cells of the tumour. (c) Fluorescence of the dye in the area of subcutaneous connective
tissue surrounding the tumour. (d) Fluorescence distribution in the space between individual tumour cells.Disib-iwi and PDT dfeck o pMhaWlcyafi
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Figwe 3 Growth curves for CaD2 tumours of
10mgkg-' injection of one of the dyes as indi
24 h later, by laser irradiation (675 rum for AlPcS1
Photofrin; 135 J CM-2 for all cases). 0, Control;
V, ALPcSI; O, AIPcS2; *, AIPCS4; A, Photofri
1ght only
Figre 4 Growth times of CaD2 tumours of
1Omg kg-' of AlPcS2 or AlPcS4 followed, variou
indicated, by laser irradiation (675 nm, 150 mW c
(see details in the text). The numbers of mice a
bottom of the columns. 'Cure' means no regrowt
tumours for the 20 days observed. The error limit
15% of the mean values.
seen in Figure 5, the efficacy of All
A1PcS4-PDT is strongly dependent upon the
the dye. The higher the dose used, the h
efficacy achieved.
PDT effect on normal skin
As shown in Figures 6 and 7, the normal ski
of the dyes at various doses and time interv
administration and light irradiation was
measuring the average thickness of feet as we
the foot reaction. Both evaluating methods
patterns of the normal foot response to PDT
post treatment. Photofrin was the most damal
feet. All dyes studied reached maximum av
2.0-2.2, except A1PcS1, which had a much
ponse score of 0.8 after PDT at a dose of IC
24 h time interval between dye administra
exposure. Photofrin-mediated PDT showed
decrease in foot photosensitivity until 12 days
did not completely recover until about 20
treatment, whereas the foot response induc
AlPcS2- or AlPcS4-based PDT was eliminal
after treatment (Figure 6a). Moreover, v
exposure was applied 2 h after the injection, b
AlPcS4 (10mg kg-') achieved a maximal scon
day after treatment, and still gave scores
respectively even 10 days post-PDT, and did
F 20
Figure 5 Growth times of CaD2 tumours in mice given i.p.
16 18 20 various doses of AlPcS, or AlPcS4 as indicated, followed, 2h
later, by light exposure. Otherwise, all conditions were the same
as those described in the legend of Figure 4.
mice given i.p.
icated followed,
,s or 632 rum for
0, light only,
recover until day 20 and day 16 following treatment (Figure
6b and d). However, when the light irradiation was per-
formed at later times (24-72 h) after injection, the foot
reaction to PDT disappeared more quickly after treatment
(Figure 6b and d). In addition, when the doses of the two
20 dyes were reduced from lOmgkg'- to mgkg-' and the
light irradiation was still given 2 h after dye administration,
15 the foot responses completely disappeared by 10 days after
10 treatment, although a score of 2.0 was reached the first day
post PDT in both cases (Figure 6c and e). These results are
A15 in good agreement with those obtained from the thickness
0 measurements of treated and untreated feet (Figure 7).
I'cS~ PDT under various conditions (dye, dye dose and time interval between dye administration and light exposure)
damaged the epidermis. However, in most cases, the epider-
mis was not completely destroyed. Degeneration and necrosis
mice given i.p. of some superficial cells occurred in the epidermis and there
is times later as was formation of vesicles in the epidermis and at the junction
m2 for 15 min) of the epidermis and the dermis (Figure 8b). Damage to
re shown at the sebaceous glands was not pronounced. Interestingly, there
h of the treated was no irreversible injury to the dermis, although vascular
ts were less than reaction in the dermis was evident, such as oedema, conges-
tion and infiltration of white blood cells. The healing of the
damaged epidermis seemed to occur promptly via epithelial
regeneration (Figure 8c), and the PDT-mediated vascular
reaction in the dermis almost disappeared within 20 days
'cS2-PDT and post treatment. These histological findings are consistent with
applied dose of the data obtained by the other two evaluating methods.
igher the PDT
DW~
PDT of cancer is based on the preferential uptake, retention
in phototoxicity (defined as the inverse of the rate of disappearance of a dye
als between dye from a tissue) and localisation of photosensitisers in neoplas-
compared by tic tissue. Thus, the elaboration of rational protocols for
11 as by grading PDT of cancer must eventually take into consideration the
showed similar following factors: (1) the kinetics of uptake and disap-
within 24 days pearance of a photosensitiser in normal and tumour tissues
ging drug to the and (2) the localisation patterns of the photosensitiser in such
rerage scores of tissues at given times. In particular, an optimal time interval
lower foot res- between drug administration and light irradiation should be
)mg kg-' and a chosen so as to reach a maximal PDT therapeutic effect on
Ltion and light the tumour as well as optimal selectivity. The reaction of
no significant singlet oxygen with target biomolecules is regarded as the
i after PDT and principal initiating pathway leading to photodynamic damage
days following (Weishaupt et al., 1976; Moan et al., 1987), although free
ed by AlPcS1-, radicals are also thought to be involved in some cases (Fer-
ted by 10 days raudi et al., 1988; Kimel et al., 1989). Since singlet oxygen
when the light diffuses intracellularly only about 20 rm in its lifetime
)oth AIPcS2 and (Moan, 1990; Moan and Berg, 1991), the cellular structures
e of 2.0 the first close to high sensitiser concentration and high oxygen con-
of 0.6 and 1.0 centration will be preferentially damaged by the activating
not completely light. Consequently, the pattern of intracellular/intratumoral
9
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Figure 6 Normal mouse skin was treated with PDT (as indicated) in the same manner as that for PDT of the tumours. Skin
phototoxicity was evaluated by grading the foot response according to arbitrary scores as described in the text.
localisation of a photosensitiser may be closely related to the
mechanism of its photodynamic action. Thus, the PDT
efficiency of cancer could be enhanced by the use of
photosensitisers with high and preferential uptake and selec-
tive localisation at particularly PDT-sensitive sites of neo-
plastic tissues.
The mechanisms involved in the preferential uptake of
dyes by tumours are not fully understood. It should be noted
that the accumulation of a drug in a tumour is actually the
result of two competing processes: uptake and disappearance.
Many sensitisers have been shown to be rapidly taken up by
various tissues, but to have different rates of clearance.
Therefore, a high retention (i.e. slow rate of disappearance) is
an important factor for preferential biodistribution of dyes.
The present study shows that the uptake and retention of
sulphonated aluminium phthalocyanines by the CaD2
tumour tissue were affected by the degree of sulphonation of
AlPcS,. The relatively less polar AIPcS. reached the highest
concentrations in the tumour tissue at 2-24 h with a slow
rate of disappearance after an i.p. injection. By contrast, the
amount of the more polar AlPcS4 peaked at I h with a fast
rate of clearance from the tumour after the injection (Figure
1). These data are in good agreement with our previous
findings in human LOX tumour tissue transplanted in nude
mice (Peng et al., 1991a, 1993). Similar results were also
found by others in mammary carcinoma of WAG/RIJ rats
by the use of a transparent observation chamber system (van
Leengoed et al., 1990, 1993b).
The preferential tumour distribution of photosensitisers is
related to their chemical properties (Kessel et al., 1987;
Kongshaug, 1992, Kessel and Woodburn, 1993). The relative
binding of porphyrins to low-density lipoprotein (LDL) inc-
reases with decreasing polarity of the dyes (Kessel et al.,
1987; Kongshaug et al., 1989, 1990a,b). There are, however,
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Fge 7 Normal mouse skin was treated (as indicated) in the same manner as that for PDT of tumours. The photoinduced skin
oedema was evaluated by measuring the thickness of treated and untreated feet of mice as described the text.
some exceptions to this rule. For example, meso-
tetraphenylporphine with two sulphonate groups on adjacent
phenyl rings (TPPS2,) was more bound to LDL than the less
polar TPPS, (Kessel et al., 1987; Kongshaug et al., 1989).
This was attributed to the asymmetry of the charges on the
dye (Kessel et al., 1987; Kongshaug et al., 1989). Such a
charge asymmetry may be a factor which leads to high
affinities for lipid-water interfaces and hence may favour not
only binding to LDL, but also uptake by cells (Bommer et
al., 1985; Berg et al., 1990). Such dyes have also a slow rate
of learance from tissues in vivo (Kessel et al., 1987; Brasseur
et al., 1988). AlPcS2, used in the present study, was supposed
to have the two sulphonate groups in adjacent positions, and
was found to bind substantially to the lipoproteins [mainly
high-density lipoprotein (HDL) and LDLJ in human plasma
(Kongshaug, 1992). It has been reported that several neoplas-
tic cell lines express larger amounts of LDL receptors than
the corresponding normal cells (Lombardi et al., 1989; Vitols
et al., 1990). These types of tumours may therefore be
involved in the mechanism of high uptake of some LDL-
binding dyes (Gal et al., 1981; Hynds et al., 1984; Norata et
al., 1984).
Light exposure of a tumour is usually carried out 24-72 h
after systemic administraion of HpD or Photofrin in most
animal and clinical trials, since in this time interval the
concentrations of the dyes are maximal in most malignant
tissues. This study has shown that, although AIPcS4 was
cleared from tumour and surrounding normal tissues faster
than was AIPcS2, the absolute amounts ofAIPcS4 at the peak
values were not lower than those of AlPcS2 (Figure 1). For a
given dye a maximal PDT effectiveness is expected when light
is applied at the time when the dye has its maximum concen-
tration in the tumour. This is supported by the findings of
the present study. The highest PDT efficincies in the CaD2
tumours were obtained when the light treatment was carried
out 2 h after AlPcS2 or AlPcS4 injection (Figure 4), the time
when the two dyes reached their maximal concentrations in
the tumours (Figure 1). This is consistent with data which
showed that AlPcS2-mediated PDT reached a maximal effect
on RIF-I murine tumours when light exposure was applied
1 h after the dye administration (Bremner et al., 1992). Also,
the present study has shown that the efficacy ofAlPcS2-PDT
and AIPcS4-PDT of the tumours is strongly dependent upon
the applied dose of the dye. The higher the drug dose used,
the higher the PDT effect achieved (Figure 5). Further,
AlPcS2 and AIPcS4 had a higher PDT-induced tumour-
destroying efficiency than had Photofrin at the same doses of
the drug and light exposure (Figure 3). Similarly, a recent
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Figure 8 Transmission microphotographs of normal mouse skin
taken before (a) and on day I (b) and day 20 (c) after PDT
treatment with AlPcS, (10mgkg-') followed. 2 h later, by light
exposure (135J cm- ).
report has shown that AlPcS, had a higher PDT efficiency in
inactivating both mouse MS-2 fibrosarcoma and mouse B16
melanoma than had HpD (Canti et al.. 1990). Surprisingly.
AlPcS1-PDT of the tumours in this study was much less
efficient than AlPcS- and AIPcS4-PDT. The reason for this
is not known. but AlPcS,is more hydrophobic than A1PcS,
and A1PcS4. Thus. aggregation may account for the above
findings. since AlPcS,has the largest tendency to aggregate.
The aggregates may not be efficiently taken up bythe tumour
tissue and also be inefficient in destruction of the tumours.
However, in some cases PDT efficacy may not only be
dependent upon the absolute amount of the sensitiser in
tumour tissue. For example. it has been shown that TPPS4 is
efficiently taken up by mouse tumour tissues (Winkelman.
1962: Evensen. 1985) and that the photochemical yield of
singlet oxygen for TPPS, in aqueous solutions is at least as
high as that for HpD (Evensen et al.. 1987). However, the
TPPS,-based PDT efficacy of C3H Tif mouse mammar- car-
cinoma is rather low (Evensen and Moan. 1987). Further. as
shown in Figure 4. AlPcS2-mediated PDT cured the CaD2
tumour (day 20 tumour-free). while the tumours resumed
growth after AlPcSg-based PDT. although the light irradia-
tion was performed when similar concentrations of the two
dyes were reached in the tumour tissue (Figure 1). It is also
true that AlPcS2-based PDT had different effects on the
tumours when the light was applied at 2 and 24 h after the
injection. although similar amounts of the dye were found in
the tumours during the time inter al of 2 -24 h after the
injection (Figure 1). Therefore. the effect of PDT on a
tumour system is not only related to the level of the dye in
the tumour. Factors such as subcellular and intratumoral
localisation patterns of the dye mav explain this.
A solid tumour contains. in addition to neoplastic cells.
vascular and interstitial compartments. No blood-borne
molecule can reach cancer cells without passing through these
compartments (Jain. 1987. 1989). Our present findings
indicate that the relatively less polar AlPcS w-as initially
localised mainlv in the vascular collagenous interstitium of
the CaD2 tumour and also. to some exteht. in the tumour
cells. Intracellular localisation of the dye was more pro-
nounced at longer times after the administration. Thus. the
intratumoral localisation pattern of the dye is time depen-
dent. The more polar AlPcS,. which binds substantialiv to
non-lipoproteins in plasma (Kongshaug. 1992). was found
largely in the stromal tissue of the tumours. These results
agree wAth data obtained in the LOX tumour model (Peng et
al.. 1991b) and in the dimethylhydrazine-induced colonic
tumours of rats (Chatlani et al.. 1992). Presumablv. AlPcS,-
based PDT resulted in destruction of the vascular supply as
well as the neoplastic cells of the tumours when light
exposure was applied 2 h after injection of the dye. whereas
AlPcS4-mediated PDT destroyed mainlv the stroma of the
tumours. Since AlPcS, had a higher photodvnamic efficiency
for tumour destruction. it seems that direct damage to
tumour cells is important to obtain a strong and lasting
effect. Thus. for a given dye the optimal time intervals
between dye administration and light irradiation might be
when substantial amounts of the dve are present in both the
vascular and neoplastic cellular compartments of tumours.
PDT of cancer aims at destroying malignant tissue while
sparing surrounding normal tissues. However. the uptake of
photosensitiser by tumour tissue is usually not as selective as
one would desire. and actually all of the currently used
porphyrin dyes are present in most non-malignant tissues in
significant amounts for a long time after systemic administra-
tion (Gomer and Dougherty. 1979: Bugelski et al.. 1981:
Peng et al.. 1987. 1991a; Bellnier et al.. 1989: Perry et al..
1991). This holds for animals and man. Exposure of normal
skin to solar and or artificial light can result in skin
photosensitivity (Meyer-Betz. 1913: Zalar et al.. 1977). At
present severe skin photosensitivity is the major side-effect of
PDT with HpD Photofrin (Razum et al.. 1987: Dougherty et
al.. 1990). This restrains the clinical application of HpD
Photofrin-based PDT. Thus. there is a need for new
photosensitisers which have more favourable photochemical
and or pharmacological properties than HpD Photofrin. In
particular. the new photosensitisers should exhibit rapid
clearance from skin and other normal tissues. The use of
such dyes would eliminate or at least reduce the extent of
skin photosensitisation.
Most of the photosensitisers studied so far have a similar
skin phototoxicitv to that of Photofrin. probably because of
a similar distribution of the dyes in the skin (Peng et al..
1990b). The present investigation shows that PDT-inducied
skin reaction. such as degeneration and necrosis of some cells
in the epidermis. and oedema. congestion and even
infiltration of inflammatory cells in the dermis. occurred only
1 day after light treatment with all the dyes examined. These
findings are in agreement with data obtained using the other
two methods. which demonstrated that the peak foot res-
ponse was reached on the first day after PDT in most cases.
Since the epidermis and dermis were not completely des-
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troyed, the skin recovered within 20 days after PDT.
Moreover. Photofrin-induced skin reactions were more severe
than those with any derivatives of AlPcSn studied. Similar
results have also been obtained by others (Tralau et al.,
1989). The extent of the foot reaction is thus related to the
dye used. Furthermore, as shown in Figures 6 and 7, factors
such as the dye dose and the time interval between dye
administration and light irradiation also affect skin phototox-
icity. In order to achieve a minimal photosensitivity of nor-
mal skin and other tissues. it is important to use suitable
dyes and dye doses on the basis of favourable distribution
properties in tumour and normal tissues. Light irradiation
should be applied at a time when the tumour,normal tissue
dye concentration ratio has its maximum value and/or when
the intratumoral localisation pattern is optimal with respect
to efficient PDT. In this way. the PDT effect on the tumour
may be optimised, while the extent of photosensitivity to
normal tissues will be minimised. However, for a maximal
tumour/normal tissue concentration ratio, the amount of the
dye in the tumour could be too low to achieve effective PDT.
In this case, either the dose of the dye given must be in-
creased or PDT must be applied at a time/times when condi-
tions are not optimal with respect to skin and/or normal
tissue photosensitivity. The advantage of eradicating tumours
is, as a rule, much larger than the drawback of skin
photosensitisation and or of some damage to normal tis-
sues.
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